Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.42 Exhibit 10.42
- 10.43 Exhibit 10.43
- 10.44 Exhibit 10.44
- 10.45 Exhibit 10.45
- 10.49 Exhibit 10.49
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 23.3 Exhibit 23.3
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- EX-FILING FEES Ex-filing Fees
Associated filings
- 2 Nov 23 S-8 POS Registration of securities for employees (post-effective amendment)
- 29 Aug 23 EFFECT Notice of effectiveness
- 28 Aug 23 424B3 Prospectus supplement
- 25 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
8 Aug 23 S-4 Registration of securities issued in business combination transactions
IMNM similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-4 of our report dated March 28, 2022, relating to the financial statements of Immunome, Inc. appearing in the Annual Report on Form 10-K of Immunome, Inc. for the year ended December 31, 2022. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Deloitte & Touche LLP
Philadelphia, Pennsylvania
August 8, 2023